Uma Krishnamurti, MD, MBBS, PhD
Professor of Pathology and Director of Breast PathologyCards
About
Titles
Professor of Pathology and Director of Breast Pathology
Director of Breast Pathology, Pathology
Biography
Dr. Krishnamurti is a pathologist with expertise in breast pathology, cytopathology, and gynecologic pathology. She completed her residency training in Anatomic and Clinical Pathology at the University of Minnesota and the University of Pittsburgh followed by a Fellowship in Cytopathology at the University of Pittsburgh. She joined the faculty at Yale in 2021, where she is currently Professor of Pathology and Director of Breast Pathology. She has been the primary author of the College of American Pathologists (CAP) gynecologic cancer reporting synoptic templates. She served as Principal Investigator and Director of the Breast Satellite Tissue Bank of Winship Cancer Institute, Emory University, from 2015 to 2021. Her main areas of academic interest include diagnostic, prognostic, and predictive markers of triple-negative and HER2-positive breast cancer.
Dr. Krishnamurti has been a course faculty at the American Society of Cytopathology (ASC), American Society for Clinical Pathology (ASCP), and College of American Pathologists (CAP) annual meetings. She has Chaired the Research and Current Concepts Committee of the ASC and served as a member of the American Joint Commission on Cancer Expert Panel on Protocol for Cancer Staging of the Vulva. Currently, Dr. Krishnamurti serves on the Breast section of the Cancer Committee of the CAP, and on the ASC Bulletin and Cytopath Podcast Committee.
Appointments
Pathology
ProfessorPrimary
Other Departments & Organizations
Education & Training
- Fellowship
- University of Pittsburgh (2004)
- Residency
- University of Pittsburgh (2003)
- PhD
- University of Minnesota (1999)
- MD
- University of Delhi (1990)
- MBBS
- University of Delhi (1985)
Board Certifications
Anatomic & Clinical Pathology
- Certification Organization
- AB of Pathology
- Original Certification Date
- 2003
Research
Publications
2025
129 Unmasking Adenomyoepithelial Lesions of the Breast: A Review of 29 Cases
Cartagena L, Liang Y, Zhan H, Krishnamurti U. 129 Unmasking Adenomyoepithelial Lesions of the Breast: A Review of 29 Cases. Laboratory Investigation 2025, 105: 102353. DOI: 10.1016/j.labinv.2024.102353.Peer-Reviewed Original Research340 Cytomorphologic Challenges in Cervical Pap Tests of Transgender Men on Androgen Therapy: A Cyto-Histological Correlation Study
Haque M, Amraei R, Iyer K, Krishnamurti U, Adeniran A, Sun T. 340 Cytomorphologic Challenges in Cervical Pap Tests of Transgender Men on Androgen Therapy: A Cyto-Histological Correlation Study. Laboratory Investigation 2025, 105: 102567. DOI: 10.1016/j.labinv.2024.102567.Peer-Reviewed Original Research401 Prognostic Value of Pelvic Washing Cytology in Early-Stage Endometrial Cancer: A 10-Year Single-Institute Cohort Study
Wang M, Abi-Raad R, Krishnamurti U, Cai G, Adeniran A, Sun T. 401 Prognostic Value of Pelvic Washing Cytology in Early-Stage Endometrial Cancer: A 10-Year Single-Institute Cohort Study. Laboratory Investigation 2025, 105: 102628. DOI: 10.1016/j.labinv.2024.102628.Peer-Reviewed Original Research116 Pathological and Molecular Characterization of Estrogen Receptor-Positive/HER2-Negative de novo Metastatic Breast Cancer
Babb P, Theriot J, Liang Y, Cartagena L, Buza N, Krishnamurti U, Zhan H. 116 Pathological and Molecular Characterization of Estrogen Receptor-Positive/HER2-Negative de novo Metastatic Breast Cancer. Laboratory Investigation 2025, 105: 102340. DOI: 10.1016/j.labinv.2024.102340.Peer-Reviewed Original Research213 Focal Atypical Ductal Hyperplasia (ADH) Upgrade Rate with Radiological Correlation: A Single Institution Study
Podany P, Kahila M, Proussaloglou E, Lewin J, Andrejeva L, Krishnamurti U. 213 Focal Atypical Ductal Hyperplasia (ADH) Upgrade Rate with Radiological Correlation: A Single Institution Study. Laboratory Investigation 2025, 105: 102437. DOI: 10.1016/j.labinv.2024.102437.Peer-Reviewed Original Research214 Histologic Analysis and Clinical Correlation of Atypical Apocrine Lesions
Podany P, Zhan H, Cartagena L, Krishnamurti U, Liang Y. 214 Histologic Analysis and Clinical Correlation of Atypical Apocrine Lesions. Laboratory Investigation 2025, 105: 102438. DOI: 10.1016/j.labinv.2024.102438.Peer-Reviewed Original ResearchGynecologic Cytology and Pap Smears
Krishnamurti U, Mosunjac M, Deftereos G. Gynecologic Cytology and Pap Smears. 2025, 1-53. DOI: 10.1007/978-981-19-7696-4_40-1.Peer-Reviewed Original ResearchAmerican Cancer SocietyCervical cancerCases of invasive cervical cancerParaffin-embedded histological samplesOncogenic HPV typesInvasive cervical cancerCancer SocietyDetection of HPVDNA in situ hybridizationCervical cancer screeningHPV genotypesHPV DNAHPV statusP16 immunohistochemistryCervical cytologyHPV typesBethesda systemHPV biologyHPVFormalin-fixedCancer screeningPrognostic reasonsHistological samplesScreening strategiesManagement guidelines
2024
Distribution of HPV 16/18 by Ethnicity and Correlation with HPV Vaccination Status
Abi-Raad R, Krishnamurti U. Distribution of HPV 16/18 by Ethnicity and Correlation with HPV Vaccination Status. Journal Of The American Society Of Cytopathology 2024, 13: s29. DOI: 10.1016/j.jasc.2024.08.052.Peer-Reviewed Original ResearchClinicopathologic Characteristics of MYC Copy Number Amplification in Breast Cancer
Sun T, Golestani R, Zhan H, Krishnamurti U, Harigopal M, Zhong M, Liang Y. Clinicopathologic Characteristics of MYC Copy Number Amplification in Breast Cancer. International Journal Of Surgical Pathology 2024, 33: 59-64. PMID: 38839260, DOI: 10.1177/10668969241256109.Peer-Reviewed Original ResearchBreast cancerCopy number amplificationClinicopathological characteristicsAssociation with <i>TP53</i> mutation. InAssociated with invasive ductal carcinomaEstrogen receptor (ER)-negativeDisease-free survival timeGene copy number amplificationC-myc immunostainingNon-amplified tumorsTP53</i> mutationsTriple-negative statusMetastatic breast cancerInvasive ductal carcinomaMYC protein overexpressionBreast cancer patientsTriple-negativeDuctal carcinomaClinicopathological featuresGenetic abnormalitiesClinical dataImmunohistochemical studiesCancer patientsProtein overexpressionSurvival timeChanging digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023
Chen-Yost H, Bammert C, Hao W, Heymann J, Lin D, Marotti J, Waraksa-Deutsch T, Huang M, Krishnamurti U, Lin O, Ly A, Moatamed N, Pantanowitz L, Roy-Chowdhuri S. Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023. Journal Of The American Society Of Cytopathology 2024, 13: 194-204. PMID: 38582697, DOI: 10.1016/j.jasc.2024.02.004.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
News
News
- March 01, 2024
Connecticut Society of Pathologists' Educational Meeting Draws Pathologists from Across the State
- December 19, 2023
Yale Pathologists Lead Effort to Revitalize Connecticut Society of Pathologists
- November 14, 2022
Yale Pathologists to Collaborate with African Physicians at Inaugural PEACE Symposium
- May 31, 2022
Uma Krishnamurti, MBBS, MD, PhD, Named New Director of Yale Breast Pathology